Study of proliferation and apoptosis in neuroblastoma.: Their relation with other prognostic factors

被引:13
作者
Mejía, MD [1 ]
Navarro, S
Pellín, A
Ruíz, A
Castel, V
Llombart-Bosch, A
机构
[1] Univ Nacl Autonoma Mexico, Lab LB 302, Dept Neurosci, Inst Fisiol Celular,CU, Mexico City 04510, DF, Mexico
[2] Univ Valencia, Fac Med, Dept Patol, Valencia, Spain
[3] Hosp La Fe, Unidad Oncol Pediat, E-46009 Valencia, Spain
关键词
neuroblastoma; proliferation; apoptosis; prognostic factors;
D O I
10.1016/S0188-4409(02)00384-3
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. Our objective was to study the proliferation and apoptotic process in 111 cases of neuroblastoma (NB) and to seek their relationship with other prognostic factors and survival. Methods. Immunohistochemistry following ABC peroxidase was carried out for PCNA, Ki-67, bcl-2, and p53 proteins. Apoptosis analysis was performed with in situ detection of chromosomal breakdown. Molecular detection of DNA ladders by electrophoresis and amplification of MYCN was studied with PCR and Southern blot. Statistical study was performed with Pearson chi(2) and Kruskal-Wallis tests and Cox regression. Results. Our results indicate that proliferative factors PCNA and Ki-67 were correlated to each other as well as to advanced stage and MYCN amplification. Regarding apoptosis, we found expression of bcl-2 protein in cases of NB without differentiation and advanced stages. p53 protein showed an inverse relation with bcl-2 and cell death measured by assay protein. In situ determination of apoptosis was found mainly in differentiated and stage 4s cases. Multivariate analysis revealed protein as the most independent risk factor of our study. Conclusions. The study of cellular proliferation and apoptosis contributes with information of prognostic value that could be applied to the design of different protocols for treatment of neuroblastoma. (C) 2002 IMSS. Published by Elsevier Science Inc.
引用
收藏
页码:466 / 472
页数:7
相关论文
共 34 条
[11]   PROGNOSTIC VALUE OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IMMUNOSTAINING IN NEUROBLASTOMA [J].
KAWASAKI, H ;
MUKAI, K ;
YAJIMA, S ;
TANAKA, R ;
TAKAYAMA, J ;
TAKASAKI, Y ;
OHIRA, M .
MEDICAL AND PEDIATRIC ONCOLOGY, 1995, 24 (05) :300-304
[12]   BAX-DEFICIENT MICE WITH LYMPHOID HYPERPLASIA AND MALE GERM-CELL DEATH [J].
KNUDSON, CM ;
TUNG, KSK ;
TOURTELLOTTE, WG ;
BROWN, GAJ ;
KORSMEYER, SJ .
SCIENCE, 1995, 270 (5233) :96-99
[13]  
KOIZUMI H, 1998, MED PEDIATR ONCOL, V31, P228
[14]   THE P53 TUMOR-SUPPRESSOR GENE [J].
LEVINE, AJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (20) :1350-1352
[15]   CLINICAL RELEVANCE OF TUMOR-CELL PLOIDY AND N-MYC GENE AMPLIFICATION IN CHILDHOOD NEUROBLASTOMA - A PEDIATRIC ONCOLOGY GROUP-STUDY [J].
LOOK, AT ;
HAYES, FA ;
SHUSTER, JJ ;
DOUGLAS, EC ;
CASTLEBERRY, RP ;
BOWMAN, LC ;
SMITH, EI ;
BRODEUR, GM .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (04) :581-591
[16]   THE LABELING OF PROLIFERATING CELLS BY KI67 AND MIB-1 ANTIBODIES DEPENDS ON THE BINDING OF A NUCLEAR-PROTEIN TO THE DNA [J].
LOPEZ, F ;
BELLOC, F ;
LACOMBE, F ;
DUMAIN, P ;
REIFFERS, J ;
BERNARD, P ;
BOISSEAU, MR .
EXPERIMENTAL CELL RESEARCH, 1994, 210 (02) :145-153
[17]   A new mutation of the p53 gene in human neuroblastoma, not correlated with N-myc amplification [J].
Mejía, C ;
Pellín, A ;
Navarro, S ;
Castel, V ;
Llombart-Bosch, A .
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 1999, 7 (03) :149-154
[18]  
Mejia MC, 1998, ANTICANCER RES, V18, P801
[19]   MUTATIONS IN THE P53 GENE OCCUR IN DIVERSE HUMAN-TUMOR TYPES [J].
NIGRO, JM ;
BAKER, SJ ;
PREISINGER, AC ;
JESSUP, JM ;
HOSTETTER, R ;
CLEARY, K ;
BIGNER, SH ;
DAVIDSON, N ;
BAYLIN, S ;
DEVILEE, P ;
GLOVER, T ;
COLLINS, FS ;
WESTON, A ;
MODALI, R ;
HARRIS, CC ;
VOGELSTEIN, B .
NATURE, 1989, 342 (6250) :705-708
[20]  
NORUSIS M, 1994, SPSS BASE WINDOWS VE, P333